Diagnostics

A $2.5M gift honors a legacy and empowers a top scientist to develop imaging tech that could revolutionize how we diagnose and treat blindness.

A surprise $5 million pledge for glaucoma research highlights a gala honoring philanthropist Daria Barry, patient advocate Hillary Golden, and music icon Nile Rodgers.

New guidelines advise biennial screening for women 50-74 and caution for others, a move that has drawn sharp criticism from other medical bodies.

New clinical consensus on ammonia and scrutiny of a standard antibiotic are creating a perfect storm for Yaqrit's promising new liver disease treatments.

Beijing's TICSSO-4 conference reveals how single-cell and spatial omics, powered by AI, are accelerating a new era in personalized healthcare.

On World Hemophilia Day, experts reveal over 75% of people with bleeding disorders are undiagnosed, facing a life of pain without access to basic care.

For over a decade, Wake Radiology has backed the Komen Race for the Cure, funding research and expanding access to life-saving breast cancer screenings.

The firm's second consecutive Data Breakthrough Award highlights its success in solving complex, decades-old data challenges for researchers globally.

New data reveals nearly 4 in 10 women lack key vaginal bacteria linked to fertility, sparking a new conversation about an invisible factor in conception.

An FDA-approved system lets surgeons see residual cancer in real-time during lumpectomies, offering new hope for avoiding the dreaded second surgery.

A new survey shows nearly half of employers are considering international drug sourcing, a legally murky strategy, as cost control dethrones talent retention.

GC Biopharma's new data on ALYGLO's purity profile could set a new standard for IVIG therapies, impacting patient safety in a rapidly growing market.

A Boston biotech says its new AI platform moves beyond correlation to find the true biological causes of disease, promising a new era for medicine.

A new DNA-based method for urine drug testing promises to eliminate invasive observation, boosting accuracy while restoring patient dignity. But is it a true revolution?

A new Finnish startup has launched with a tech that could detect cancer years earlier by amplifying protein signals, aiming to shift healthcare to prevention.

A new partnership integrates expert rater training with eCOA tech, aiming to reduce costly data errors and accelerate development of new neurological drugs.

A new AI platform is the first to get EU approval for predicting fertility treatment timing, promising to boost success rates and ease clinic workloads.

Aetrex and Tradehome Shoes will provide free 3D foot scans and custom orthotics to thousands of athletes at the 2026 Special Olympics USA Games.

TEDCO's latest funding round seeds 13 university-born ventures, tackling everything from hereditary hearing loss and cancer to environmental monitoring.

A CEO's personal battle with prostate cancer inspired a community golf tournament that is now on the verge of raising $1 million for critical research.